One World Products Remains Pre-Revenue, Faces Funding Hurdles
Ticker: OWPC · Form: 10-K · Filed: Jun 3, 2025 · CIK: 1622244
| Field | Detail |
|---|---|
| Company | One World Products, Inc. (OWPC) |
| Form Type | 10-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: Pharmaceuticals, Pre-revenue, Biotech, Penny Stock, High Risk, SEC Filing, Capital Raise
Related Tickers: OWPC
TL;DR
**OWPC is a pre-revenue gamble; avoid until they show actual sales and a clear path to profitability.**
AI Summary
One World Products, Inc. (OWPC) reported no revenue for the fiscal year ended December 31, 2024, consistent with the prior year, indicating a pre-revenue stage. The company's net loss for 2024 was not explicitly stated but can be inferred from the lack of revenue and ongoing operational costs. Key business changes include the continued development of its pharmaceutical preparations business, operating under the SIC code 2834. Significant risks involve the company's reliance on future capital raises, as evidenced by its pre-revenue status and the need to fund operations. The strategic outlook focuses on advancing its product pipeline and securing necessary financing, with a reported fiscal year end of December 31, 2024. The company's business address is 6605 Grand Montecito Pkwy, Suite 100, Las Vegas, NV 89149, and its phone number is 702-605-0605.
Why It Matters
One World Products' continued pre-revenue status for the fiscal year ended December 31, 2024, signals high risk for investors, as the company has yet to generate any sales. This lack of revenue generation means employees' job security is tied directly to successful future capital raises and product development. Customers are not yet impacted as there are no products on the market, but the broader pharmaceutical preparations market (SIC 2834) will only see competitive impact if OWPC successfully commercializes its offerings. The company's ability to secure funding will dictate its survival and potential market entry.
Risk Assessment
Risk Level: high — The risk level is high because One World Products, Inc. reported no revenue for the fiscal year ended December 31, 2024, and the prior year, indicating a complete lack of commercial operations. The company's reliance on external financing to fund its pharmaceutical preparations business, without any current income stream, presents significant going concern risks.
Analyst Insight
Investors should exercise extreme caution and avoid investing in OWPC until the company demonstrates a clear path to revenue generation and provides concrete evidence of product commercialization. Monitor future filings for signs of successful capital raises and initial sales figures.
Financial Highlights
- revenue
- $0
- revenue Growth
- 0.0%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Pharmaceutical Preparations | $0 | 0.0% |
Key Numbers
- $0 — Revenue (Reported for fiscal year ended December 31, 2024, indicating pre-revenue status.)
- 2024-12-31 — Fiscal Year End (The period covered by this 10-K filing.)
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations, defining the company's industry.)
Key Players & Entities
- One World Products, Inc. (company) — filer of the 10-K
- OWPC (company) — ticker symbol
- 0001622244 (regulator) — Central Index Key (CIK)
- 6605 Grand Montecito Pkwy, Suite 100, Las Vegas, NV 89149 (company) — business address
- 702-605-0605 (company) — business phone number
- 03 Life Sciences (company) — organization name
- Nevada (company) — state of incorporation
- Pharmaceutical Preparations (company) — Standard Industrial Classification (SIC) industry
- One World Pharma, Inc. (company) — former company name
- PUNTO GROUP, CORP. (company) — former company name
FAQ
What was One World Products, Inc.'s revenue for the fiscal year 2024?
One World Products, Inc. reported no revenue for the fiscal year ended December 31, 2024, indicating it remains in a pre-revenue stage of development.
What industry does One World Products, Inc. operate in?
One World Products, Inc. operates in the Pharmaceutical Preparations industry, as indicated by its Standard Industrial Classification (SIC) code 2834.
What are the primary risks for investors in One World Products, Inc.?
The primary risks for investors in One World Products, Inc. include its pre-revenue status, meaning no sales have been generated, and its reliance on future capital raises to fund operations and product development.
When was One World Products, Inc.'s 10-K filed?
One World Products, Inc.'s 10-K was filed on June 3, 2025, covering the fiscal period ended December 31, 2024.
Has One World Products, Inc. changed its name previously?
Yes, One World Products, Inc. was formerly known as One World Pharma, Inc. until January 25, 2019, and before that, PUNTO GROUP, CORP. until October 14, 2014.
What is the business address of One World Products, Inc.?
The business address for One World Products, Inc. is 6605 Grand Montecito Pkwy, Suite 100, Las Vegas, NV 89149.
What is the Central Index Key (CIK) for One World Products, Inc.?
The Central Index Key (CIK) for One World Products, Inc. is 0001622244, which is used by the SEC to identify the company.
What is the strategic outlook for One World Products, Inc.?
The strategic outlook for One World Products, Inc. involves continued development of its pharmaceutical preparations pipeline and securing necessary financing to transition from a pre-revenue company to a commercial entity.
How does One World Products, Inc.'s financial position impact its employees?
One World Products, Inc.'s pre-revenue financial position means employee job security is highly dependent on the company's ability to successfully raise capital and eventually commercialize products, as there is no current revenue stream to support operations.
What is the significance of the 'Related Party' and 'Nonrelated Party' mentions in the filing?
The mentions of 'Related Party' and 'Nonrelated Party' in the filing typically refer to financial transactions or balances with entities or individuals connected to the company's management or significant shareholders versus those with independent third parties, which are important for assessing potential conflicts of interest or financing sources.
Risk Factors
- Reliance on Future Financing [high — financial]: The company is in a pre-revenue stage and has no reported revenue for the fiscal year ended December 31, 2024. This necessitates ongoing reliance on future capital raises to fund operations, development, and potential commercialization efforts.
- Product Development and Commercialization [high — operational]: As a company focused on pharmaceutical preparations, One World Products, Inc. faces inherent risks in the lengthy and costly process of research, development, clinical trials, and regulatory approval. Success is not guaranteed, and delays or failures can significantly impact financial performance.
- Regulatory Compliance [high — regulatory]: Operating within the pharmaceutical industry (SIC 2834) subjects the company to stringent regulatory oversight from bodies like the FDA. Failure to comply with evolving regulations, manufacturing standards, or approval processes can lead to significant delays, fines, or product rejection.
- Competitive Landscape [medium — market]: The pharmaceutical preparations market is highly competitive, with established players and emerging companies. One World Products, Inc. must differentiate its products and effectively compete for market share, which can be challenging given its pre-revenue status.
Industry Context
One World Products, Inc. operates in the Pharmaceutical Preparations industry (SIC 2834). This sector is characterized by high research and development costs, lengthy product development cycles, and stringent regulatory hurdles. The competitive landscape includes both large, established pharmaceutical giants and smaller, specialized biotech firms, all vying for market share through innovation and effective commercialization strategies.
Regulatory Implications
As a pharmaceutical company, One World Products, Inc. is subject to extensive regulation by agencies like the FDA. Compliance with Good Manufacturing Practices (GMP), clinical trial protocols, and drug approval processes is critical. Any misstep in regulatory adherence can lead to significant delays, increased costs, or outright failure to bring products to market.
What Investors Should Do
- Monitor future financing rounds closely.
- Track progress in product pipeline development.
- Evaluate management's ability to navigate regulatory pathways.
Key Dates
- 2024-12-31: Fiscal Year End — Marks the end of the reporting period for the 10-K filing, providing a snapshot of the company's financial position and performance.
- 2025-06-03: 10-K Filing Date — The date the company officially submitted its annual report to the SEC, making detailed financial and operational information publicly available.
Glossary
- SIC Code 2834
- Standard Industrial Classification code for Pharmaceutical Preparations, indicating the company's primary business activity in the development and manufacturing of drugs and medicines. (Defines the industry in which One World Products, Inc. operates, highlighting the regulatory and market dynamics associated with pharmaceutical products.)
- Pre-revenue stage
- A phase in a company's lifecycle where it has not yet generated any sales revenue, typically characterized by significant investment in research, development, and infrastructure. (Explains why One World Products, Inc. reported $0 revenue and underscores its reliance on external funding for operations.)
- 10-K Filing
- An annual report required by the U.S. Securities and Exchange Commission (SEC) that gives a comprehensive summary of a company's financial performance. (This document provides the detailed information analyzed here, including financial statements, risk factors, and business overview.)
Year-Over-Year Comparison
The company reported $0 revenue for the fiscal year ended December 31, 2024, which is consistent with the prior year, indicating no change in its pre-revenue status. No specific financial metrics like net income, margins, or debt-to-equity ratios were readily available in the provided snippet to compare against the previous filing. The core risks related to financing and product development remain prominent.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on June 3, 2025 regarding One World Products, Inc. (OWPC).